CN Patent

CN107793368B — 达可替尼溶剂化物、其新晶型及其制备方法和用途

Assigned to Sichuan Kelun Pharmaceutical Research Institute Co Ltd · Expires 2021-10-15 · 5y expired

What this patent protects

本发明涉及达可替尼新晶型及其制备方法和用途。本发明的达可替尼的晶型在理化性能，比如稳定性等方面具有优异的性质。

USPTO Abstract

本发明涉及达可替尼新晶型及其制备方法和用途。本发明的达可替尼的晶型在理化性能，比如稳定性等方面具有优异的性质。

Drugs covered by this patent

Patent Metadata

Patent number
CN107793368B
Jurisdiction
CN
Classification
—
Expires
2021-10-15
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Kelun Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.